Chairman & Managing Partner, Munich and Dubai
Since joining TVM Capital in 1990, Dr. Schuehsler has been the deal maker on more than 30 direct investments in life science companies in Europe and the U.S. In total he has overseen more than 100 investments in the life science industry and has built the TVM Capital Life Science practice as an internal start up within the firm to its international market position today.
On the life science side, he is currently a board member of bispecific antibody focused F-Star Group of Companies (Vienna/Cambridge, UK) and anti-infectives company, Biovertis AG (Vienna/Munich) and has previously held positions as chairman, vice chairman or board member for more than 20 innovative life science companies. In 2007 and 2008, Dr. Schuehsler served as chairman of Invest Europe (formerly the European Private Equity and Venture Capital Association (EVCA)). On the emerging markets private equity side he currently serves as chairman of Manzil Home Health Services (Abu Dhabi) and Bourn Hall International (Dubai/Delhi) and is a member of the board of directors at Ameco Medical Industries (Cairo) and Cambridge Medical and Rehabilitation Center (Abu Dhabi). He previously held the position of chairman at ProVita International Medical Center.
Dr. Schuehsler was a member of the Selection Committee for the Technology Pioneers program, the Steering Committee of the Entrepreneurship and Successful Growth Research Program of the World Economic Forum (2009-2012).